Novel finding could lead to new therapies for asthma, COPD
January 28th, 2011 - 5:40 pm ICT by ANIWashington, Jan 28 (ANI): Scientists from a University of Texas Medical Branch at Galveston have demonstrated that a single “master switch” enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease (COPD).
The enzyme’s action can be blocked by drugs whose safety has been shown in clinical trials for other diseases.
The discovery could improve therapies for the 510 million people worldwide suffering from asthma and COPD.
Using cell culture and laboratory mouse experiments, the researchers showed that the enzyme, aldose reductase, is essential to a process known as goblet cell metaplasia that is seen in both asthma and COPD. In goblet cell metaplasia, exposure to allergens such as pollen, mold and dust mites initiates a series of biochemical reactions that causes the cells that line the air passages of the lungs to change from their normal state into so-called “goblet cells,” which produce substantial amounts of excess mucus.
“The discovery that aldose reductase regulates mucus production and goblet cell metaplasia makes inhibition of this enzyme an attractive therapeutic option to reduce mucus-related airway obstructive diseases - and for the first time gives us a real chance to alter the course of the underlying disease in asthma and COPD,” said UTMB Health biochemistry and molecular biology professor Satish Srivastava, senior author of the paper.
The findings have been published in the online journal PLoS One. (ANI)
- Indian origin boffin's discovery may lead to powerful new asthma treatment - Aug 12, 2009
- Protein shows promise in treating smoker's diseases - Jan 16, 2012
- Delayed symptoms ravage asthmatics - Aug 14, 2011
- New therapeutic target for asthma, other lung disorders identified - Apr 18, 2011
- Key mechanism of childhood respiratory disease identified - Mar 08, 2011
- Bitter tasting substances 'found to work better than drugs to treat asthma' - Oct 25, 2010
- Climate change will also worsen respiratory diseases - Mar 15, 2012
- Cigarette smoking ups production of mucus in patients with bronchitis - Feb 18, 2011
- Four novel biomarkers that may help diagnose asthma, COPD identified - Mar 12, 2011
- Cell component that triggers cat allergy identified - Mar 10, 2011
- Culprit behind severe allergic asthma discovered - Aug 30, 2010
- Cigarette smoke may cause inflammation through a new chemical pathway - Sep 03, 2010
- Re-engineered toxins can treat asthma, arthritis - Jan 02, 2012
- Novel drug may benefit cystic fibrosis patients - Dec 18, 2010
- Controlled oxygen therapy slashes death rate among COPD patients - Oct 22, 2010
Tags: air passages, allergens, biochemical reactions, biochemistry and molecular biology, biology professor, cell culture, chronic obstructive pulmonary disease, dust mites, excess mucus, laboratory mouse, master switch, metaplasia, mucus production, obstructive pulmonary disease, plos one, substantial amounts, texas medical branch, therapeutic option, university of texas medical branch, university of texas medical branch at galveston